Drug intelligence / Profile preview

Hyalograft C (Fidia Advanced Biopolymers)

Development stage
Discontinued
Lead developer
Anika Therapeutics
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Cell Therapies, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Implant
01

Overview

**Hyalograft C** is a patient-specific, matrix-associated autologous chondrocyte transplantation product for surgical cartilage repair. It contains autologous chondrocytes harvested from the patient, expanded ex vivo, and seeded onto a three-dimensional HYAFF-11 scaffold composed of esterified hyaluronic acid; the implanted construct is intended to fill focal cartilage defects and support regeneration of cartilage-like tissue. It was developed for symptomatic traumatic full-thickness cartilage defects of the medial or lateral femoral condyle or trochlea of the knee in adults. The product is a combined advanced therapy medicinal product because the cell therapy incorporates a scaffold medical device. ([ema.europa.eu](https://www.ema.europa.eu/en/medicines/human/EPAR/hyalograft-c-autograft))

Brand names
Hyalograft C
Other names
Hyalograft C autograftHyalograft-C

Beyond the preview

Go deeper on Hyalograft C (Fidia Advanced Biopolymers).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hyalograft C (Fidia Advanced Biopolymers).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call